Critical Dietary Factors in Cancer Chemoprevention (PDF)

Name: Critical Dietary Factors in Cancer Chemoprevention
Brand: Springer-Verlag GmbH
SKU: 70451265
Price: 98.99 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Critical Dietary Factors in Cancer Chemoprevention".

Merken

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 98.99 €

Buch (Gebunden) 109.99 €

sofort als Download lieferbar

Bestellnummer: 70451265

Printausgabe 109.99 €

eBook (pdf) -10% 98.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Critical Dietary Factors in Cancer Chemoprevention (PDF)“

This book focuses on the prophylactic potential of diet-derived factors in primary prevention of cancer. It is written by a group of highly reputed experts in the area of dietary agents and cancer chemoprevention. The translational potential of dietary factors from epidemiological, laboratory and clinical studies as prevention strategy in normal and risk populations is highlighted. The work presents options of routine inclusion of specific dietary regimens for prevention as well as therapeutic strategy for better management through adjuvant interventions in cancer treatment.

Autoren-Porträt

Mohammad Fahad Ullah is Assistant Professor of biochemistry at the Faculty of Applied Medical Sciences and a Research scientist at Prince Fahd Research Centre, University of Tabuk, Saudi Arabia. He received his academic degrees in biochemistry from Aligarh Muslim University, India, followed by studies on cancer cell signaling in cellular & animal models of lung and pancreatic cancer at Experimental Oncology laboratory, Department of Biomedical & Diagnostic Sciences, University of Tennessee, USA. His research interest is in the field of novel plant- or diet-derived chemopreventive compounds and the assessment of their mechanism of action and translational potential. He is member of the editorial / reviewer board of a number of scientific journals. Aamir Ahmad is a Research Scientist at the Wayne State University, Dpt. of Pathology, and Barbara Ann Karmanos Cancer Institute, Detroit, MI. His research interests include elucidating novel targets for therapy in aggressive breast cancers with special focus on key signaling pathways and microRNAs-mediated regulation of metastases and drug-resistance. Dr. Ahmad has authored close to 150 scientific publications and also serves as an academic editor for the journal PLOS One.